Affiliation:
1. From the Graduate Institute of Life Sciences and Departments of Medical Research (T.-C.C.), Pharmacology (M.-H.Y.), Anesthesiology (C.-Y.L.), Tri-Service General Hospital; the National Defense Medical Center; and the Division of Cardiology, Veterans General Hospital (Y.-A.D.), Taipei, Republic of China.
Abstract
Abstract
—The activity and protein expression of endothelial nitric oxide synthase (eNOS) and inducible NOS (iNOS) were investigated during the development of hypertension in spontaneously hypertensive rats (SHR). SHR and Wistar-Kyoto rats (WKY) were studied at three different ages: 4, 14 to 17, and 63 weeks of age. After treatment with saline or lipopolysaccharide (LPS, 10 mg/kg IV) for 3 hours, the aortas were removed for measurement of NOS activity and protein expression assay by [
3
H]-
l
-citrulline formation method and Western blot analysis, respectively. Plasma levels of nitrite/nitrate (NO
2
−
/NO
3
−
) and tumor necrosis factor-α (TNF-α) were also determined. At 14 to 17 weeks and 63 weeks, the basal activity and protein expression of eNOS in the aortas were significantly lower in SHR than in WKY. In addition, the aged WKY exhibited lower eNOS activity than that of adult WKY, but this change was not seen in SHR. By comparison, the basal activity and protein expression of iNOS were only observed in SHR of the 14-to-17-week group and in the 63-week group; SHR still exhibited higher activities, and these differences were further exaggerated by treatment with LPS. The basal and LPS-induced NO
2
−
/NO
3
−
and TNF-α levels in the plasma were also higher in the SHR except the 4-week group. After treatment with quinapril, the basal and LPS-induced expressions of iNOS in SHR were significantly attenuated. Our results demonstrated that alterations of activity and protein expression of eNOS and iNOS occurred in SHR. In addition, aging may reduce the activity of eNOS in WKY but not in SHR. The decline of eNOS activity and/or expression may contribute to the development of hypertension, whereas the increase of iNOS expression may be a consequence of the pathological state of vessels associated with hypertension in SHR. However, the augmented expression of iNOS in SHR was attenuated by antihypertensive therapy, suggesting that the abnormal expression of iNOS is associated with hypertension.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
306 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The life cycle of a capillary: Mechanisms of angiogenesis and rarefaction in microvascular physiology and pathologies;Vascular Pharmacology;2024-09
2. Role of Herbal Active Compound in Cardiac Failure Treatment;Journal for Research in Applied Sciences and Biotechnology;2024-04-13
3. New Dawn for Atherosclerosis: Vascular Endothelial Cell Senescence and Death;International Journal of Molecular Sciences;2023-10-13
4. Lymphatic vessels and the renin-angiotensin-system;American Journal of Physiology-Heart and Circulatory Physiology;2023-10-01
5. Endothelial Function;Prevention and Management of Cardiovascular and Metabolic Disease;2023-04-14